Latest News for: gsk
Edit
Germany Anemia Treatment Market Forecast and Company Analysis Report 2026-2034 Featuring Akebia Therapeutics, GSK, Vertex, ...
Nasdaq Globe Newswire 24 Apr 2026
Edit
Top FTSE 100 shares to watch next week: Lloyds, Barclays, GSK, Natwest
Invezz 24 Apr 2026
The FTSE 100 Index pulled back this week as the US-Iran war continued and after the UK published a hot consumer inflation report ... Similarly, GlaxoSmithKline, popularly known as GSK, has formed a double-top-like pattern, signaling potential retreat.
Edit
FTSE 100 Index retreats ahead of Lloyds, Barclays, Natwest, GSK earnings
Invezz 23 Apr 2026
The FTSE 100 Index pulled back for three consecutive days as companies exposed to the ongoing US-Iran war slipped and as the UK published a strong inflation report. It also dropped as market participants waited for the upcoming UK corporate earnings.
Edit
Notice of Election of Directors (GSK - GlaxoSmithKline Pakistan Ltd)
Public Technologies 23 Apr 2026
) ... You can access the original document here ... Disclaimer. GSK - GlaxoSmithKline Pakistan Ltd.
Edit
Miscellaneous Information (GSK - GlaxoSmithKline Pakistan Ltd)
Public Technologies 22 Apr 2026
) ... You can access the original document here ... Disclaimer. GSK - GlaxoSmithKline Pakistan Ltd.
Edit
Prior Publication of Notice of Election of Directors (GSK - GlaxoSmithKline Pakistan Ltd)
Public Technologies 22 Apr 2026
) ... You can access the original document here ... Disclaimer. GSK - GlaxoSmithKline Pakistan Ltd.
Edit
Total Investment of Approx. USD 8.5 Million in Malaria and NTD R&D Projects With Partners Including MMV, GSK, Tanabe Pharma, Eisai and DNDi
PR Newswire 22 Apr 2026
Prolyl tRNA synthetase inhibitors as a new antimalarial project led by MMV, GSK (GlaxoSmithKline Investigacion y Desarrollo, S.L.), and the University of Tokyo ... (GSK).
Edit
Anaptys Completes Separation of First Tracks Biotherapeutics and Now Exclusively Manages GSK and Vanda Financial Collaborations
Nasdaq Globe Newswire 20 Apr 2026
Edit
Caledonian Record
20 Apr 2026
Anaptys Completes Separation of First Tracks Biotherapeutics and Now Exclusively Manages GSK
Focused on protecting and returning value of Jemperli and imsidolimab royalties to shareholdersLaunches with virtual model, including limited FTEs and minimal operating expenses, and approximately $140-$145 million in net cash ....
Edit
Board Meeting Quarter 1- 2026 (GSK - GlaxoSmithKline Pakistan Ltd)
Public Technologies 20 Apr 2026
). 20th April 2026. The General Manager. Pakistan Stock Exchange Limited Stock Exchange Building ... T +92 21 111475 725. Dear Sir,. SUBJECT. Board of Directors Meeting ... Thanking you, ... Hina Mir. Company Secretary ... Disclaimer. GSK - GlaxoSmithKline Pakistan Ltd.
Edit
Anaptys Completes Separation of First Tracks Biotherapeutics and Now Exclusively Manages GSK and Vanda Financial Collaborations (Form 8-K) (AnaptysBio Inc)
Public Technologies 20 Apr 2026
Manages GSK and Vanda Financial Collaborations • ... Anaptys will now exclusively manage the financial collaborations for Jemperli with GSK and imsidolimab with Vanda with a focus on protecting and returning the value of its royalties to shareholders.
Edit
Blenrep (belantamab mafodotin) approved in China for treatment of 2L+ relapsed/refractory multiple myeloma (Form 6-K) (GSK plc)
Public Technologies 20 Apr 2026
GSK plc ... GSK plc (LSE/NYSE ... Hesham Abdullah, Senior Vice President, Global Head Oncology, R&D, GSK, said ... GSK in oncology ... About GSK ... Find out more at www.gsk.com. GSK enquiries ... [5] GSK press release issued 9 December 2024 ... GSK plc ... behalf of GSK plc.
- 1
- 2
- Next page »